The Inscripta® Blog
February 8, 2022
"Digital Genome Engineering: Unlocking the Potential of Synthetic Biology" Symposium Highlights
Inscripta partnered with Build With Biology to put on a half-day virtual symposium “Digital Genome Engineering: Unlocking the Potential of…
February 1, 2022
Inside Inscripta: Steven Alvarez, Systems Integration
We continue to introduce Scripters who recently joined the company and today’s guest is Steven Alvarez, Scientist on the Systems Integration…
January 25, 2022
JP Morgan 2022: The Promise of Synthetic Biology
The healthcare industry kicks off each new year not when the ball drops in Times Square but with the start of the annual JP Morgan Healthcare…
January 18, 2022
Ginkgo Bioworks Incorporates the Onyx® platform into its foundries
Ginkgo Bioworks, the leading horizontal platform for cell programming, has recently adopted the Onyx platform into its foundries. The company…
January 11, 2022
What Makes CRISPR Like a Movie Star? SynBioBeta podcast with Nandini Krishnamurthy
Nandini Krishnamurthy, Inscripta’s VP of Microbial Business, appeared as a guest on SynBioBeta’s Built with Biology podcast. The new podcast…
January 4, 2022
Inside Inscripta: Gözde Gencer, System Integration
What’s one of the most important elements for introducing a game-changing technology like our Onyx® Genome Engineering Platform? A team of…
December 21, 2021
Inscripta’s MAD7™ CRISPR Nucleases Helping Hudson River Biosciences Improve Plant Editing
In a recent webinar, Ben Mijts of Inscripta, and Gabino Sanchez of Hudson River Biotechnology, demonstrate how Inscripta’s MADzyme™ family of…
December 14, 2021
New Market Report Finds Near-Boundless Opportunity in Synthetic Biology
A new U.S. thematic market report from Barclays’ Equity Research team shines a spotlight on the tremendous potential in the Synthetic Biology…
December 7, 2021
Inside Inscripta: Reem Baraka, Sequencing
While Inscripta is a genome engineering company, we also make heavy use of DNA sequencing — so much that we have a high-capacity internal…